Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Zolpidem Tartrate Patent Expiration

Zolpidem Tartrate was first introduced by Cosette Pharmaceuticals Inc in its drug Ambien on Dec 16, 1992. Other drugs containing Zolpidem Tartrate are Edluar, Ambien Cr, Tovalt Odt, Zolpimist, Zolpidem Tartrate, Intermezzo. 36 different companies have introduced drugs containing Zolpidem Tartrate.


Zolpidem Tartrate Patents

Given below is the list of patents protecting Zolpidem Tartrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zolpimist US8236285 Buccal, polar and non-polar spray containing zolpidem Aug 07, 2032 Aytu
Edluar US9265720 Pharmaceutical formulations useful in the treatment of insomnia Feb 25, 2031 Viatris
Intermezzo US8242131 Methods of treating middle-of-the-night insomnia Aug 20, 2029 Purdue Pharma
Intermezzo US7658945 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof Apr 15, 2027 Purdue Pharma
Edluar US9597281 Pharmaceutical formulations useful in the treatment of insomnia Apr 06, 2027 Viatris
Intermezzo US7682628 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof Feb 16, 2025

(Expired)

 Purdue Pharma
Intermezzo US8252809 Compositions for treating insomnia Feb 16, 2025

(Expired)

 Purdue Pharma
Ambien Cr US6514531

(Pediatric)

 Controlled-release dosage forms comprising zolpidem or a salt thereof Jun 01, 2020

(Expired)

 Cosette
Ambien Cr US6514531 Controlled-release dosage forms comprising zolpidem or a salt thereof Dec 01, 2019

(Expired)

 Cosette
Edluar US6761910 Pharmaceutical composition for the treatment of acute disorders Sep 24, 2019

(Expired)

 Viatris
Edluar US8512747 Pharmaceutical composition for the treatment of acute disorders Sep 24, 2019

(Expired)

 Viatris
Zolpimist US7632517 Buccal, polar and non-polar spray containing zolpidem Oct 01, 2017

(Expired)

 Aytu



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Zolpidem Tartrate's patents.

Given below is the list recent legal activities going on the following patents of Zolpidem Tartrate.

Activity Date Patent Number
Patent litigations
Expire Patent
Critical
 15 Jan, 2018 US7632517
Expire Patent
Critical
 02 Sep, 2016 US8236285
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 09 Apr, 2014 US7632517
Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted
Critical
 09 Apr, 2014 US7632517
Petition Decision - Accept Late Payment of Maintenance Fees - Granted
Critical
 09 Apr, 2014 US7632517
Petition to Accept Late Payment of Maintenance Fee Payment Filed
Critical
 09 Apr, 2014 US7632517
Expire Patent
Critical
 10 Jan, 2014 US7632517
Patent Issue Date Used in PTA Calculation
Critical
 07 Aug, 2012 US8236285
Recordation of Patent Grant Mailed
Critical
 07 Aug, 2012 US8236285
Issue Notification Mailed
Critical
 18 Jul, 2012 US8236285


Zolpidem Tartrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Zolpidem Tartrate Generic API Manufacturers

Several generic applications have been filed for Zolpidem Tartrate. The first generic version for Zolpidem Tartrate was by Sun Pharmaceutical Industries Inc and was approved on Apr 23, 2007. And the latest generic version is by Breckenridge Pharmaceutical Inc and was approved on Jun 4, 2020.

Given below is the list of companies who have filed for Zolpidem Tartrate generic, along with the locations of their manufacturing plants worldwide.


1. ACME LABS

The Acme Laboratories Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Acme Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB Apr 23, 2007
10MG

tablet Prescription ORAL AB Apr 23, 2007





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6.25MG

tablet, extended release Discontinued ORAL N/A Oct 13, 2010
12.5MG

tablet, extended release Discontinued ORAL N/A Jun 6, 2011


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6.25MG

tablet, extended release Discontinued ORAL N/A Mar 25, 2013
12.5MG

tablet, extended release Discontinued ORAL N/A Mar 25, 2013





4. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6.25MG

tablet, extended release Discontinued ORAL N/A Sep 10, 2013
12.5MG

tablet, extended release Discontinued ORAL N/A Sep 10, 2013


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Brantford Apotex Pharmachem Inc.
Etobicoke Apotex, Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
Winnipeg Apotex Fermentation Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





5. APOTEX INC

Apotex Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Apotex Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007


Manufacturing Plant Locations
New

Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.

Country City Firm Name
Canada
North York Apotex Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.





6. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Prescription ORAL AB May 4, 2007
5MG

tablet Prescription ORAL AB May 4, 2007


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Bachupally Aurobindo Pharma Limited
Sangareddy Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
United States
East Windsor Aurobindo Pharma USA Inc





7. BRECKENRIDGE

Breckenridge Pharmaceutical Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Breckenridge.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5MG

tablet, extended release Discontinued ORAL N/A Jun 4, 2020
6.25MG

tablet, extended release Discontinued ORAL N/A Jun 4, 2020


Manufacturing Plant Locations
New

Breckenridge's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Breckenridge as present at those locations.

Country City Firm Name
United States
Boca Raton Breckenridge Pharmaceutical, Inc.
Berlin Breckenridge Pharmaceutical, Inc





8. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB Jul 30, 2012
10MG

tablet Prescription ORAL AB Jul 30, 2012





9. DR REDDYS

Dr Reddys Laboratories Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.75MG

tablet Prescription SUBLINGUAL AB Nov 18, 2016
3.5MG

tablet Prescription SUBLINGUAL AB Nov 18, 2016





10. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007





11. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
12.5MG

tablet, extended release Discontinued ORAL N/A Dec 3, 2010
6.25MG

tablet, extended release Discontinued ORAL N/A Apr 14, 2011
5MG

tablet Prescription SUBLINGUAL AB Aug 1, 2016
10MG

tablet Prescription SUBLINGUAL AB Aug 1, 2016
1.75MG

tablet Prescription SUBLINGUAL AB Sep 11, 2017
3.5MG

tablet Prescription SUBLINGUAL AB Sep 11, 2017





12. HIKMA

Hikma Pharmaceuticals has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 30, 2008
10MG

tablet Discontinued ORAL N/A Apr 30, 2008


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





13. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Sep 7, 2007
10MG

tablet Discontinued ORAL N/A Sep 7, 2007





14. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6.25MG

tablet, extended release Prescription ORAL AB Sep 11, 2013
12.5MG

tablet, extended release Prescription ORAL AB Sep 11, 2013


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





15. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007





16. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued SUBLINGUAL N/A Aug 8, 2016
5MG

tablet Discontinued SUBLINGUAL N/A Aug 8, 2016





17. NOVEL LABS INC

Novel Laboratories Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.5MG

(reference standard)

tablet Prescription SUBLINGUAL AB Jun 3, 2015
1.75MG

tablet Prescription SUBLINGUAL AB Jun 3, 2015





18. RISING

Rising Pharma Holding Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Phoenix Rising Sun Farms Inc
Livingston Risingsun Iodine Products Corp.
Rising Sun Rising Sun Veterinary Clinic
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
East Brunswick Rising Pharma Holding, Inc.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Saddle Brook Rising Pharmaceuticals, Inc.
Fort Bragg Rising Tide Sea Vegetables
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





19. SANDOZ

Sandoz Inc has filed for 4 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB Apr 23, 2007
10MG

tablet Prescription ORAL AB Apr 23, 2007
6.25MG

tablet, extended release Prescription ORAL AB Jul 1, 2011
12.5MG

tablet, extended release Prescription ORAL AB Jul 1, 2011


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





20. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Nov 21, 2008
10MG

tablet Discontinued ORAL N/A Nov 21, 2008


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
Chestnut Ridge Strides Pharma, Inc.
East Brunswick Strides Pharma Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





21. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6.25MG

tablet, extended release Prescription ORAL AB Jan 24, 2017
12.5MG

tablet, extended release Prescription ORAL AB Jan 24, 2017


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Lexington Sun Pharmaceutical Industries Inc
Billerica Sun Pharmaceutical Industries, Inc.
India
Punjab Sun Pharmaceutical Industries, Inc.
Vadodara Sun Pharmaceutical Industries Ltd
Mohali Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Bharuch Sun Pharmaceutical Industries Ltd
Baruch Sun Pharmaceutical Industries Ltd.
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
New Delhi Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Vadodara Sun Pharmaceutical Industries Ltd.
Halol Sun Pharmaceutical Industries Ltd.
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Ahmednagar Sun Pharmaceutical Industries Limited
Dadra Sun Pharmaceutical Industries Limited





22. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007





23. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007





24. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued ORAL N/A Apr 23, 2007
5MG

tablet Discontinued ORAL N/A Apr 23, 2007





25. SYNTHON PHARMS

Synthon Pharmaceuticals Inc has filed for 4 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Synthon Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007
6.25MG

tablet, extended release Discontinued ORAL N/A Apr 12, 2011
12.5MG

tablet, extended release Discontinued ORAL N/A Jun 6, 2011





26. TEVA

Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB Apr 23, 2007
10MG

tablet Prescription ORAL AB Apr 23, 2007


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
Fort Dodge TEVA Animal Health Inc
Miami Teva Branded Pharmaceutical Products R & D, Inc.
India
Bhind Teva API India Ltd- Malanpur
Gajraula, Amroha Teva API India Private Ltd.
Canada
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Stouffville Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





27. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Prescription ORAL AB Aug 17, 2007
5MG

tablet Prescription ORAL AB Aug 17, 2007





28. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007





29. WOCKHARDT

Wockhardt Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A May 15, 2007
10MG

tablet Discontinued ORAL N/A May 15, 2007


Manufacturing Plant Locations
New

Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.

Country City Firm Name
India
Aurangabad Wockhardt Limited
Ankleshwar Wockhardt, Ltd.
Solan, Nalagarh Wockhardt Limited - Baddi





30. YUNG SHIN PHARM

Yung Shin Pharmaceutical Industrial Co Ltd has filed for 2 different strengths of generic version for Zolpidem Tartrate. Given below are the details of the strengths of this generic introduced by Yung Shin Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 23, 2007
10MG

tablet Discontinued ORAL N/A Apr 23, 2007


Manufacturing Plant Locations
New

Yung Shin Pharm's manufacturing plants are situated in 2 countries - China, Taiwan. Given below are the details of these plant locations as well as the firm names of Yung Shin Pharm as present at those locations.

Country City Firm Name
China
Kunshan Yung Shin Pharmaceutical Industrial (Kunshan) Co., Ltd.
Taiwan
Taichung City Yung Shin Pharmaceutical Industry Co., Ltd.